Variant report
Variant | nsv1032945 |
---|---|
Chromosome Location | chr9:24512538-24572818 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:19)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:24542908-24543131 | HepG2 | liver: | n/a | chr9:24542993-24543004 |
2 | CEBPB | chr9:24562320-24562452 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr9:24565572-24565772 | A549 | lung: | n/a | n/a |
4 | CEBPB | chr9:24556332-24556354 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CEBPB | chr9:24556226-24556465 | HepG2 | liver: | n/a | chr9:24556345-24556356 |
6 | CTCF | chr9:24535287-24535360 | Kidney_OC | kidney: | n/a | n/a |
7 | E2F4 | chr9:24551652-24551844 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr9:24519573-24519904 | MCF10A-Er-Src | breast: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519735-24519743 |
9 | FOS | chr9:24516577-24516760 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | FOS | chr9:24519598-24519904 | MCF10A-Er-Src | breast: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519735-24519743 |
11 | FOS | chr9:24519580-24519902 | MCF10A-Er-Src | breast: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519735-24519743 |
12 | FOS | chr9:24519572-24519886 | MCF10A-Er-Src | breast: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519735-24519743 |
13 | FOS | chr9:24519517-24519764 | HUVEC | blood vessel: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519735-24519743 |
14 | FOXA1 | chr9:24552571-24552842 | T-47D | breast: | n/a | chr9:24552747-24552762 |
15 | GATA3 | chr9:24552518-24552837 | T-47D | breast: | n/a | n/a |
16 | GATA3 | chr9:24512686-24513051 | SK-N-SH | brain: | n/a | n/a |
17 | GATA3 | chr9:24518810-24519003 | SH-SY5Y | brain: | n/a | n/a |
18 | GATA3 | chr9:24552520-24552785 | T-47D | breast: | n/a | n/a |
19 | GATA3 | chr9:24533058-24533642 | SK-N-SH | brain: | n/a | n/a |
20 | IRF3 | chr9:24550167-24550195 | GM12878 | blood: | n/a | n/a |
21 | JUND | chr9:24519647-24519737 | H1-hESC | embryonic stem cell: | n/a | n/a |
22 | JUND | chr9:24519575-24519842 | HepG2 | liver: | n/a | chr9:24519736-24519743 chr9:24519735-24519744 chr9:24519734-24519743 chr9:24519733-24519744 chr9:24519735-24519743 |
23 | MAFF | chr9:24518557-24518910 | HepG2 | liver: | n/a | chr9:24518722-24518740 |
24 | MAFF | chr9:24570021-24570192 | HepG2 | liver: | n/a | chr9:24570084-24570102 |
25 | MAFK | chr9:24526008-24526183 | HepG2 | liver: | n/a | chr9:24526085-24526101 |
26 | MAFK | chr9:24538547-24538747 | HepG2 | liver: | n/a | n/a |
27 | MAFK | chr9:24518563-24518938 | H1-hESC | embryonic stem cell: | n/a | chr9:24518724-24518739 |
28 | MAFK | chr9:24518550-24518916 | IMR90 | lung: | n/a | chr9:24518724-24518739 |
29 | MAFK | chr9:24569940-24570203 | HepG2 | liver: | n/a | chr9:24570085-24570100 |
30 | MAFK | chr9:24562618-24562852 | HepG2 | liver: | n/a | n/a |
31 | MAFK | chr9:24569959-24570239 | HepG2 | liver: | n/a | chr9:24570085-24570100 |
32 | MAFK | chr9:24518562-24518904 | HepG2 | liver: | n/a | chr9:24518724-24518739 |
33 | MAFK | chr9:24518640-24518877 | Hela-S3 | cervix: | n/a | chr9:24518724-24518739 |
34 | MAFK | chr9:24569988-24570124 | H1-hESC | embryonic stem cell: | n/a | chr9:24570085-24570100 |
35 | MAFK | chr9:24518551-24518919 | HepG2 | liver: | n/a | chr9:24518724-24518739 |
36 | MAFK | chr9:24538553-24538753 | IMR90 | lung: | n/a | n/a |
37 | MAZ | chr9:24518084-24518113 | HepG2 | liver: | n/a | n/a |
38 | MYC | chr9:24534452-24534652 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr9:24513288-24513417 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr9:24515940-24516306 | H1-neurons | neurons: | n/a | n/a |
41 | POLR2A | chr9:24527379-24527415 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr9:24522739-24522803 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr9:24526697-24526972 | H1-neurons | neurons: | n/a | n/a |
44 | POLR2A | chr9:24518684-24518778 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | POLR2A | chr9:24569765-24569957 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | POLR2A | chr9:24569889-24570054 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | POLR2A | chr9:24570190-24570359 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr9:24556741-24556742 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr9:24519383-24519453 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr9:24550518-24550668 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:19 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMRTA1-7 | chr9:24545856-24546127 | XLOC_007304 |
2 | lnc-DMRTA1-7 | chr9:24545996-24546127 | ENSG00000269957.1 |
3 | lnc-DMRTA1-7 | chr9:24551961-24552127 | ENSG00000269957.1 |
4 | lnc-DMRTA1-7 | chr9:24561754-24561848 | XLOC_007304 |
5 | lnc-DMRTA1-7 | chr9:24545423-24545526 | XLOC_007304 |
6 | lnc-DMRTA1-7 | chr9:24552919-24553237 | ENSG00000269957.1 |
7 | lnc-DMRTA1-7 | chr9:24545422-24546127 | XLOC_007304 |
8 | lnc-DMRTA1-7 | chr9:24561754-24561848 | ENSG00000269957.1 |
9 | lnc-DMRTA1-7 | chr9:24551961-24552127 | ENSG00000269957.1 |
10 | lnc-DMRTA1-7 | chr9:24551961-24552156 | XLOC_007304 |
11 | lnc-DMRTA1-7 | chr9:24545856-24546127 | XLOC_007304 |
12 | lnc-DMRTA1-7 | chr9:24561325-24561428 | XLOC_007304 |
13 | lnc-DMRTA1-7 | chr9:24545400-24545526 | XLOC_007304 |
14 | lnc-DMRTA1-7 | chr9:24561754-24561848 | XLOC_007304 |
15 | lnc-DMRTA1-7 | chr9:24551961-24552127 | XLOC_007304 |
16 | lnc-DMRTA1-7 | chr9:24545422-24546127 | XLOC_007304 |
17 | lnc-DMRTA1-7 | chr9:24552919-24553082 | XLOC_007304 |
18 | lnc-DMRTA1-7 | chr9:24545950-24546127 | ENSG00000269957.1 |
19 | lnc-DMRTA1-7 | chr9:24561754-24561848 | XLOC_007304 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IZUMO3 | TF binding region |
ENSG00000269957 | TF binding region |
LEPROTL1 | miRNA target sites |
ZDHHC17 | miRNA target sites |
MAP3K3 | miRNA target sites |
FRS2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544700043 | chr9:24520401-24520402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564286586 | chr9:24520442-24520443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35082908 | chr9:24520450-24520451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183988846 | chr9:24520474-24520475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540526705 | chr9:24520540-24520541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560150800 | chr9:24520573-24520574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376167241 | chr9:24520574-24520575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16908415 | chr9:24520633-24520634 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs548616372 | chr9:24520650-24520651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535743696 | chr9:24520652-24520653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562124743 | chr9:24520657-24520658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557339307 | chr9:24520665-24520666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531340357 | chr9:24520691-24520692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs28528362 | chr9:24520725-24520726 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs575533025 | chr9:24520726-24520727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188637012 | chr9:24520826-24520827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540430802 | chr9:24520879-24520880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112723865 | chr9:24520890-24520891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368666215 | chr9:24520894-24520895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567097995 | chr9:24520912-24520913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147269812 | chr9:24520940-24520941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546305918 | chr9:24520953-24520954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575673551 | chr9:24520988-24520989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139932367 | chr9:24520989-24520990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558233683 | chr9:24521014-24521015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577781279 | chr9:24521020-24521021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564237771 | chr9:24521023-24521024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540097784 | chr9:24521036-24521037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560294111 | chr9:24521058-24521059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192248471 | chr9:24521067-24521068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542499891 | chr9:24521156-24521157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149405110 | chr9:24521204-24521205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531180064 | chr9:24521249-24521250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551065684 | chr9:24521294-24521295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184379781 | chr9:24521331-24521332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564082888 | chr9:24521391-24521392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546906151 | chr9:24521396-24521397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs16908420 | chr9:24522412-24522413 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs188722560 | chr9:24522431-24522432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs115501402 | chr9:24522442-24522443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529801417 | chr9:24522479-24522480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116643738 | chr9:24522501-24522502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532080348 | chr9:24522502-24522503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373707389 | chr9:24522515-24522516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552018340 | chr9:24522524-24522525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565159189 | chr9:24522533-24522534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150957710 | chr9:24522534-24522535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547584995 | chr9:24522535-24522536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186085879 | chr9:24522556-24522557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs536325895 | chr9:24522582-24522583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Lung cancer | 21569311 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:24520400-24521400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr9:24522400-24522800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr9:24542200-24542800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:24545200-24545600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr9:24545200-24546200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr9:24546200-24547200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr9:24547400-24547600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr9:24552600-24553000 | Enhancers | Fetal Kidney | kidney |
9 | chr9:24553000-24553200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
10 | chr9:24571600-24571800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr9:24571800-24572200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr9:24571800-24580000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr9:24572200-24572600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr9:24572200-24573200 | Enhancers | Adipose Nuclei | Adipose |
15 | chr9:24572600-24573400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |